India could see drug shortages, price rise owing to new rule: Industry executives

A recent notification by the health ministry covers the revised Schedule M rules for good manufacturing practices and requirements of premises, plant and equipment for pharmaceutical products, with provisions for an annual product quality review as well as quality risk management and a pharmaceutical quality system.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LoIsaic
via gqrds